Ultragenyx Pharmaceutical(CH:UP0)
CHF 13.53+0.02 (+0.14%)
CH:UP0
Ultragenyx Pharmaceutical earnings date
CHF 13.53
At close:+0.02 (+0.14%)
Ultragenyx Pharmaceutical (UP0) Q4 2021 Earnings Report
0 Followers
CH:UP0 Q4 2021 EPS Results
- Actual EPS
- -CHF 1.50
- Consensus EPS
- -CHF 1.16
- Beat/Miss
- Missed by -CHF 0.35
- One Year Ago EPS
- -CHF 0.31
CH:UP0 Q4 2021 Revenue Results
- Actual Revenue
- CHF 70.11M
- Expected Revenue
- CHF 70.45M
- Beat/Miss
- Missed by -CHF 343.03K
- YoY Revenue Growth
- -8.91%
Earnings Announcement Details
- Quarter
- Q4 2021
- Date
- 02/10/2022
- Time
- After Close
- Conference Call
- Thursday, February 10, 2022
CH:UP0 Upcoming Earnings
Ultragenyx Pharmaceutical's next earnings date is estimated for February 18, 2027, based on past reporting schedules.
Q4 2021 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q4 2021 Earnings Slide Deck
No slide deck is available for this earnings event.
Q4 2021 Earnings Call Summary
No earnings call summary is available for this earnings event.
CH:UP0 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 18, 2027 | 2026 (Q4) | 1.99- | -1.08 | ― | ― |
| Nov 03, 2026 | 2026 (Q3) | -0.92-0.98 | -1.52 | 35.91% (+0.55) | |
| Aug 04, 2026 | 2026 (Q2) | -1.04-0.76 | -0.98 | 23.08% (+0.23) | |
| May 05, 2026 | 2026 (Q1) | -1.25-1.55 | -1.32 | -17.20% (-0.23) | |
| Feb 12, 2026 | 2025 (Q4) | -0.92-1.08 | -1.17 | 7.19% (+0.08) | |
| Nov 04, 2025 | 2025 (Q3) | -1.04-1.52 | -1.18 | -29.29% (-0.34) | |
| Aug 05, 2025 | 2025 (Q2) | -1.09-0.98 | -1.28 | 23.03% (+0.29) | |
| May 06, 2025 | 2025 (Q1) | -1.34-1.32 | -1.71 | 22.66% (+0.39) | |
| Feb 13, 2025 | 2024 (Q4) | -1.10-1.17 | -1.28 | 8.55% (+0.11) | |
| Nov 05, 2024 | 2024 (Q3) | -1.25-1.18 | -1.87 | 37.22% (+0.70) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

